Literature DB >> 20230413

HCV genotype 2 as a risk factor for reactivation in patients with B-cell lymphoma undergoing rituximab combination chemotherapy.

Vincenzo Pitini, Giuseppe Sturniolo, Carmela Arrigo, Silvana Leonardi, Salvatrice Pino, Giuseppe Altavilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20230413     DOI： 10.1111/j.1365-2141.2010.08154.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Authors:  Michele Merli; Carlo Visco; Michele Spina; Stefano Luminari; Virginia Valeria Ferretti; Manuel Gotti; Sara Rattotti; Valeria Fiaccadori; Chiara Rusconi; Clara Targhetta; Caterina Stelitano; Alessandro Levis; Achille Ambrosetti; Davide Rossi; Luigi Rigacci; Alfonso Maria D'Arco; Pellegrino Musto; Annalisa Chiappella; Luca Baldini; Maurizio Bonfichi; Luca Arcaini
Journal:  Haematologica       Date:  2013-11-22       Impact factor: 9.941

2.  Reactivation of hepatitis C virus with severe hepatitis flare during steroid administration for interstitial pneumonia.

Authors:  Kosuke Sato; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tomoaki Iwata; Akitoshi Sano; Mio Tsuruoka; Atsushi Masamune
Journal:  Clin J Gastroenterol       Date:  2021-05-13

Review 3.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

Review 5.  Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

6.  'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.

Authors:  Massimo Marignani; Michela di Fonzo; Paola Begini; Elia Gigante; Ilaria Deli; Adriano M Pellicelli; Sara Gallina; Emanuela de Santis; Gianfranco Delle Fave; M Christina Cox
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

Review 7.  Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives.

Authors:  Ying-Chun Shen; Chiun Hsu; Ann-Lii Cheng
Journal:  J Gastroenterol       Date:  2010-06-22       Impact factor: 6.772

8.  HCV virus and lymphoid neoplasms.

Authors:  Yutaka Tsutsumi; Shinichi Ito; Reiki Ogasawara; Kazuhiro Kudo; Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Adv Hematol       Date:  2011-07-05

9.  Differences in the patterns and outcomes of enhanced viral replication between hepatitis C virus and hepatitis B virus in patients with hepatocellular carcinoma during transarterial chemolipiodolization.

Authors:  Pil Soo Sung; Si Hyun Bae; Jeong Won Jang; Do Seon Song; Hee Yeon Kim; Sun Hong Yoo; Chung Hwa Park; Jung Hyun Kwon; Myeong Jun Song; Chan Ran You; Jong Young Choi; Seung Kew Yoon
Journal:  Korean J Hepatol       Date:  2011-12

Review 10.  Rituximab-based treatment, HCV replication, and hepatic flares.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Caterina Sagnelli; Nicola Coppola
Journal:  Clin Dev Immunol       Date:  2012-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.